Direct injection of vasopressin during hysteroscopic myomectomy: a case report.

Abstract

BACKGROUND:

Hysteroscopic myomectomy is the ideal procedure for symptomatic women with submucosalfibroids who desire to preserve their fertility. Vascular myomas can limit visualization when a mechanical morcellator is used. Injection of a dilute vasopressin solution has been shown to decrease blood loss during laparoscopic myomectomy. To date, direct injection of a dilute vasopressin during hysteroscopic myomectomy has not been described.

CASE:

Our first patient's hysteroscopic myomectomy of a vascular submucosal myoma had to be terminated before complete resection due to impaired visualization and maximum fluid overload. During a subsequent patient's procedure, direct injection ofa dilute vasopressin through the operative port decreased intraoperaftve bleeding and enabled complete resection.

CONCLUSION:

Injecting a dilute vasopressin solution directly into a vascular submucosal myoma during hysteroscopic resection can assist with hemostasis and visualization, enabling complete resection.

• Authors: M Brigid Holloran-Schwartz, Kallie Harrison, Richard Gimpelson
• Journal: The Journal of reproductive medicine (J Reprod Med) 2014 Nov-Dec Vol. 59 Issue 11-12 Pg. 614-6 ISSN: 0024-7758 [Print] United States
• PMID: 25552139 (Publication Type: Case Reports, Journal Article)

Chemical References

• Hemostatics
• Vasopressins

Topics

• Blood Loss, Surgical (prevention & control)
• Female
• Hemostatics (administration & dosage)
• Humans
• Hysteroscopy (methods)
• Injections, Intralesional
• Leiomyoma (surgery)
• Middle Aged
• Uterine Myomectomy (methods)
• Uterine Neoplasms (surgery)
• Vasopressins (administration & dosage)